Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vår Energi ASA’s share saving plan allocates shares

Sandnes, Norway, 2 December 2024: A total of 511 785 shares were purchased on behalf of employees in Vår Energi ASA (OSE: VAR) participating in the company’s employee share saving programme. The average purchase price was NOK 36.254 per share. The transactions are based on savings made in October, November, and December 2024. 86% of Vår Energi employees took part in the share saving for these months. As part of the programme, primary insiders in Vår Energi ASA (OSE: VAR) purchased 15 041 shares at an average price of NOK 36.254 per share. Details on individual allocation of shares to

Brevik Carbon Capture Plant Reaches Mechanical Completion

Aker Carbon Capture ASA (ACC ASA) has reached a significant milestone with the mechanical completion of the world's first full-scale carbon capture facility at a cement plant, the Heidelberg Materials Brevik plant in Norway.ACC ASA holds 20% ownership in SLB Capturi, which is delivering CO₂ capture, conditioning, compression, heat integration, intermediate storage and loading facility for the plant. The carbon capture plant is designed to capture 400,000 metric tons of CO\2 \annually from the cement facility. The development will now move into commissioning phase and is planned to be

Brevik Carbon Capture Plant Reaches Mechanical Completion

SLB Capturi, a joint venture between SLB and Aker Carbon Capture ASA (ACC ASA), an Aker Horizons portfolio company, announced the mechanical completion of the carbon capture plant at Heidelberg Materials’ cement facility in Brevik, Norway, a significant milestone for the CCS project.ACC ASA holds 20% ownership in SLB Capturi, which is delivering CO₂ capture, conditioning, compression, heat integration, intermediate storage and loading facility for the plant. The carbon capture plant is designed to capture 400,000 metric tons of CO\2 \annually from the cement facility. The development will

Total Voting Rights

           Vesuvius plc 2 December 2024   Vesuvius plc - Voting Rights and Capital   In conformity with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, Vesuvius plc confirms that at the date of this announcement it has an issued share capital of 266,478,288 Ordinary Shares of 10 pence each. 7,271,174 of these Ordinary Shares are held in Treasury. Therefore, the total number of Vesuvius plc shares with voting rights is 259,207,114. The above figure of 259,207,114 shares may be used by shareholders as the denominator for the calculations by which

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 02.12.2024

Fiskars Corporation   Stock Exchange Release 02.12.2024 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 02.12.2024   Date 02.12.2024  Exchange transaction Buy  Share class FSKRS  Amount  2,000  Average price/share 14.7560 EURHighest price/share 14.7600 EURLowest price/share 14.6800 EURTotal price 29,512.00 EUR        The shares held by Fiskars Corporation on 02.12.2024:   FSKRS  111,111       On

EQT AB’s Nomination Committee for the Annual Shareholders’ Meeting 2025

EQT AB’s Nomination Committee for the Annual Shareholders’ Meeting 2025 has been appointed based on the ownership structure as of 31 August 2024.The Nomination Committee consists of  Jacob Wallenberg (Chairperson), appointed by Investor AB Cynthia Lee, appointed by Jean Eric Salata Harry Klagsbrun, appointed by Conni JonssonJoachim Spetz, appointed by Swedbank Robur Funds Conni Jonsson, Chairperson of the Board of EQT AB  As of 31 August 2024, shareholders having appointed members to the Nomination Committee together represented approximately 29 percent of the voting rights

#24-414 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-413 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Cavendish Hydrogen ASA: Mandatory Notification of Trade by Primary Insiders

(December 2[nd], 2024 – Oslo, Norway) Jon Andrè Løkke, Chair of the Board of Directors in Cavendish Hydrogen ASA (“Cavendish Hydrogen”) has purchased 32 000 shares in Cavendish Hydrogen at an average price of NOK 8.89 per share.Ludens AS has today purchased 25 000 shares in Cavendish Hydrogen at an average price of NOK 9.24 per share. Ludens AS is a company controlled by Jon Andrè Løkke. Following the transactions today, Jon Andrè Løkke holds 34 000 shares in Cavendish Hydrogen. Ludens AS holds 25 000 shares in Cavendish Hydrogen. The total shareholding in Cavendish Hydrogen of Jon Andrè

ExpreS2ion announces approval to initiate a Phase I clinical trial of ES2B-C001, its novel therapeutic vaccine, being developed for HER2-expressing breast cancer

Hørsholm, Denmark, 2 December 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion"), a clinical-stage biotechnology company with a focused portfolio of vaccine candidates targeting infectious diseases and cancer, is proud to announce the approval of its Phase I clinical trial application (CTA) by the Austrian Agency for Health and Food Safety for its novel therapeutic vaccine candidate, ES2B-C001, against HER2-expressing breast cancer.Bent U. Frandsen, Chief Executive Officer said: “This is the first time we advance a development project into the

Total Voting Rights

2 December 2024 15:00 GMT Transparency DirectiveVoting rights and capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 30 November 2024 the issued share capital of AstraZeneca PLC with voting rights is 1,550,317,189 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,550,317,189. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they

StocExpo 2025 marks 20[th] anniversary with new Clean Ammonia Storage Conference and networking party in central Rotterdam

Rotterdam, Netherlands – 24 October 2024 – StocExpo, the world's leading tank storage and energy infrastructure event, is set to celebrate its 20th edition in March 2025 in Rotterdam with an exciting array of new features, partnerships, and global initiatives.As the event celebrates two decades of success, this milestone edition will ensure the international tank storage community has access to the latest in robotics, future fuels infrastructure and safety equipment. · Brand new Clean Ammonia Storage Conference: A new partnership with NH3 Event will provide a dedicated platform to

Mandatory Notification of Trade

Hamilton, Bermuda, December 2, 2024 - Paratus Energy Services Ltd. (ticker "PLSV") (the "Company") has been notified of a trade completed by a fund managed by Lodbrok Capital LLP, a close associate to board member Joachim Bale. For further information, please see the attached mandatory notification of trade. This information is subject to the disclosure requirements in articles 19 of the Regulation EU 596/2014 (the EU Market Abuse Regulation) and section 5-12 of the Norwegian Securities Trading Act.

Aker Solutions ASA: Reporting of transactions made by persons discharging managerial responsibilities

December 2, 2024 – Aker Solutions ASA (“Aker Solutions”) has today allocated shares to primary insiders participating in the company’s manager share purchase program for 2024.Reference is made to the stock exchange release published earlier today, December 2, 2024, concerning the manager share purchase program and share allocation. Aker Solutions sold shares to program participants at a price per share of NOK 30.422, which equals the volume-weighted average share price of Aker Solutions on Euronext Oslo Børs from and including November 25, 2024, to and including November 29, 2024. The

Aker Solutions ASA: Sale of own shares for Manager Share Purchase Program

December 2, 2024 – Aker Solutions ASA (“Aker Solutions”) has sold own shares in connection with the company’s manager share purchase program for 2024.The program entitled selected managers of the company in Norway to purchase Aker Solutions shares through cash payment, without any discount or price reduction offered. Participants who remain employed and have not sold any program shares as of December 31, 2027, will, however, receive matching shares in the ratio 1:2; one matching share for every two shares acquired under the program. The program was launched by Aker Solutions on November

Lundbeck completes acquisition of Longboard

· A significant step forward in Lundbeck’s Focused Innovator strategy and advancing the goal of building a robust neuro-rare franchise · The lead asset, bexicaserin, holds blockbuster potential and is in development for the treatment of DEEs in a program enrolling patients diagnosed with Dravet syndrome, Lennox-Gastaut syndrome, and other DEE syndromes · Bexicaserin has shown encouraging anti-seizure effects to date in preclinical and clinical studies, with its next-generation superagonist mechanism specifically targeting 5-HT2C receptors, supporting bexicaserin’s potential to offer a

Teneo.ai and Kenway Consulting Partner to Deliver Industry-Leading IVR Solutions with Unmatched NLU Accuracy

Innovative Collaboration Streamlines IVR Migrations, Boosting Efficiency and Accuracy for Enterprises WorldwideTeneo.ai , a pioneer in next-generation Voice AI, proudly announces a strategic partnership with Kenway Consulting , a leader in call center solutions and contact center consulting. This collaboration combines Teneo’s cutting-edge voice automation and its NLU Accuracy Booster™ with Kenway’s extensive expertise in IVR modernization to revolutionize contact center automation. The partnership brings unparalleled accuracy and

There are no items matching the current filter
There are no more items matching the current filter
Back to top